Does bronchial hyperresponsiveness predict a diagnosis of cough variant asthma in adults with chronic cough: a cohort study

Respir Res. 2021 Sep 23;22(1):252. doi: 10.1186/s12931-021-01845-2.

Abstract

Bronchial hyperresponsiveness is a typical, but non-specific feature of cough variant asthma (CVA). This study aimed to determine whether bronchial hyperresponsiveness may be considered as a predictor of CVA in non-smoking adults with chronic cough (CC). The study included 55 patients with CC and bronchial hyperresponsiveness confirmed in the methacholine provocation test, in whom an anti-asthmatic, gradually intensified treatment was introduced. The diagnosis of CVA was established if the improvement in cough severity and cough-related quality of life in LCQ were noted.The study showed a high positive predictive value of bronchial hyperresponsiveness in this population. Cough severity and cough related quality of life were not related to the severity of bronchial hyperresponsiveness in CVA patients. A poor treatment outcome was related to a low baseline capsaicin threshold and the occurrence of gastroesophageal reflux-related symptoms. In conclusion, bronchial hyperresponsiveness could be considered as a predictor of cough variant asthma in non-smoking adults with CC.

Keywords: Asthma; Bronchial hyperresponsiveness; Cough.

Publication types

  • Clinical Trial
  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Anti-Asthmatic Agents / pharmacology
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / complications
  • Asthma / diagnosis*
  • Asthma / drug therapy
  • Bronchial Hyperreactivity / diagnosis*
  • Bronchial Hyperreactivity / drug therapy
  • Bronchial Hyperreactivity / etiology
  • Bronchial Provocation Tests / methods*
  • Chronic Disease
  • Cohort Studies
  • Cough / diagnosis*
  • Cough / drug therapy
  • Cough / etiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies

Substances

  • Anti-Asthmatic Agents